TY  - JOUR
AU  - Santoro, Francesco
AU  - Núñez-Gil, Ivan J
AU  - Viana-Llamas, María C
AU  - Maroun Eid, Charbel
AU  - Romero, Rodolfo
AU  - Fernández Rozas, Inmaculada
AU  - Aparisi, Alvaro
AU  - Becerra-Muñoz, Victor Manuel
AU  - García Aguado, Marcos
AU  - Huang, Jia
AU  - Maltese, Ludovica
AU  - Cerrato, Enrico
AU  - Alfonso-Rodriguez, Emilio
AU  - Castro Mejía, Alex Fernando
AU  - Marin, Francisco
AU  - Raposeiras Roubin, Sergio
AU  - Pepe, Martino
AU  - Moreno Munguia, Victor H
AU  - Feltes, Gisela
AU  - Navas, Jesus Varas
AU  - Cortese, Bernardo
AU  - Buzón, Luis
AU  - Liebetrau, Cristoph
AU  - Ramos-Martinez, Raquel
AU  - Fernandez-Ortiz, Antonio
AU  - Estrada, Vicente
AU  - Brunetti, Natale Daniele
PY  - 2021
DO  - 10.1097/CCM.0000000000005010
UR  - http://hdl.handle.net/10668/17589
T2  - Critical care medicine
AB  - No standard therapy, including anticoagulation regimens, is currently recommended for coronavirus disease 2019. Aim of this study was to evaluate the efficacy of anticoagulation in coronavirus disease 2019 hospitalized patients and its impact on...
LA  - en
KW  - Anticoagulants
KW  - COVID-19
KW  - Case-Control Studies
KW  - Correlation of Data
KW  - Cross-Cultural Comparison
KW  - Hemorrhage
KW  - Hospitalization
KW  - Humans
KW  - Multicenter Studies as Topic
KW  - Outcome Assessment, Health Care
KW  - Prospective Studies
KW  - Registries
KW  - Respiration, Artificial
KW  - Respiratory Insufficiency
KW  - Risk
KW  - Survival Rate
KW  - Treatment Outcome
KW  - COVID-19 Drug Treatment
TI  - Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]).
TY  - research article
VL  - 49
ER  -